Multiparametric MRI and CT Models of Infarct Core and Favorable Penumbral Imaging Patterns in Acute Ischemic Stroke
暂无分享,去创建一个
Max Wintermark | Jeffry R Alger | Jason Hom | Reza Jahan | David S Liebeskind | T. J. Schaewe | Jeffrey L Saver | M. Wintermark | J. Alger | J. Gornbein | R. Jahan | D. Liebeskind | S. Starkman | J. Saver | C. Kidwell | D. D. De Silva | T. Jovin | M. Jumaa | Tudor Jovin | Sidney Starkman | Chelsea S Kidwell | Deidre A De Silva | Jeffrey Gornbein | J. Hom | Timothy J Schaewe | Mouhammad Jumaa | Jeffrie Schreier | J. Schreier
[1] Scott Hamilton,et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.
[2] Leif Østergaard,et al. How Reliable Is Perfusion MR in Acute Stroke?: Validation and Determination of the Penumbra Threshold Against Quantitative PET , 2008, Stroke.
[3] F. Buonanno,et al. Predicting Tissue Outcome in Acute Human Cerebral Ischemia Using Combined Diffusion- and Perfusion-Weighted MR Imaging , 2001, Stroke.
[4] M Fisher,et al. Characterizing the target of acute stroke therapy. , 1997, Stroke.
[5] Gregory W Albers,et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.
[6] Kirsten Shuler,et al. Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: Definitions and thresholds , 2011, Annals of neurology.
[7] G. Albers,et al. Applications of diffusion–perfusion magnetic resonance imaging in acute ischemic stroke , 1999, Neurology.
[8] Scott Hamilton,et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study , 2006, Annals of neurology.
[9] W. Heiss,et al. Does the Mismatch Match the Penumbra?: Magnetic Resonance Imaging and Positron Emission Tomography in Early Ischemic Stroke , 2005, Stroke.
[10] J. Alger,et al. Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging , 2003, Stroke.
[11] D. Darby,et al. Results from the pilot phase of the Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) , 2002 .
[12] Jeffry R Alger,et al. Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue , 2003, Stroke.
[13] G. Schlaug,et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion‐weighted magnetic resonance imaging , 1997, Annals of neurology.
[14] P. Adeleine,et al. Baseline Magnetic Resonance Imaging Parameters and Stroke Outcome in Patients Treated by Intravenous Tissue Plasminogen Activator , 2003, Stroke.
[15] R. Gonzalez,et al. MRI-Based Selection for Intra-Arterial Stroke Therapy: Value of Pretreatment Diffusion-Weighted Imaging Lesion Volume in Selecting Patients With Acute Stroke Who Will Benefit From Early Recanalization , 2009, Stroke.
[16] Ting-Yim Lee,et al. White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion study. , 2008, Radiology.
[17] G. Albers,et al. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. , 1999, Stroke.
[18] M. Moseley,et al. Optimal Definition for PWI/DWI Mismatch in Acute Ischemic Stroke Patients , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[19] H Soltanian-Zadeh,et al. A Model for Multiparametric MRI Tissue Characterization in Experimental Cerebral Ischemia With Histological Validation in Rat: Part 1 , 2001, Stroke.
[20] Keith Muir,et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.
[21] Gary A. Ford,et al. Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) , 2008, Stroke.
[22] E. Kanal,et al. The Cortical Ischemic Core and Not the Consistently Present Penumbra Is a Determinant of Clinical Outcome in Acute Middle Cerebral Artery Occlusion , 2003, Stroke.
[23] T. J. Schaewe,et al. Design and Rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial , 2014, International journal of stroke : official journal of the International Stroke Society.
[24] Christopher Putman,et al. Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated With Intra-Arterial Thrombolysis:: Prediction of Final Infarct Volume and Clinical Outcome , 2001, Stroke.
[25] G. Schlaug,et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. , 1999, Neurology.
[26] Gary Duckwiler,et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging , 2000, Annals of neurology.
[27] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[28] M. Kaste,et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.
[29] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[30] V Hachinski,et al. Identification of Penumbra and Infarct in Acute Ischemic Stroke Using Computed Tomography Perfusion–Derived Blood Flow and Blood Volume Measurements , 2006, Stroke.
[31] P. S. Jones,et al. The Diffusion-Weighted Lesion in Acute Stroke: Heterogeneous Patterns of Flow/Metabolism Uncoupling as Assessed by Quantitative Positron Emission Tomography , 2005, Cerebrovascular Diseases.
[32] Reto Meuli,et al. Perfusion-CT Assessment of Infarct Core and Penumbra: Receiver Operating Characteristic Curve Analysis in 130 Patients Suspected of Acute Hemispheric Stroke , 2006, Stroke.
[33] M. Chopp,et al. Multiparametric MRI Tissue Characterization in Clinical Stroke With Correlation to Clinical Outcome: Part 2 , 2001, Stroke.
[34] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[35] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[36] A. Padovani,et al. Perfusion CT in Patients with Acute Ischemic Stroke Treated with Intra-Arterial Thrombolysis: Predictive Value of Infarct Core Size on Clinical Outcome , 2009, American Journal of Neuroradiology.
[37] S. Warach,et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study , 2009, The Lancet Neurology.
[38] G Marchal,et al. Voxel-based mapping of irreversible ischaemic damage with PET in acute stroke. , 1999, Brain : a journal of neurology.